ENHANCEMENT OF ACTIVITY AND/OR DURATION OF ACTION OF SELECTED ANTI-INFLAMMATORY STEROIDS
申请人:BODOR, Nicholas S.
公开号:EP1658083B1
公开(公告)日:2007-08-08
Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
申请人:Bodor S. Nicholas
公开号:US20050020551A1
公开(公告)日:2005-01-27
Methods and compositions for enhancing the activity and/or duration of action of soft anti-inflammatory steroids of the haloalkyl 17α-alkoxy-11β-hydroxyandrost-4-en-3-one-17β-carboxylate type and the corresponding Δ
1,4
compounds and of anti-inflammatory steroids of the hydrocortisone and prednisolone type are described. The enhancing agents have the formula:
wherein R is H or C
1
-C
4
alkyl; Z
1
is carbonyl or β-hydroxymethylene; X
1
is —O— or —S—; R
5
is —OH, —OR
6
, —OCOOR
6
or —OCOR
7
wherein R
6
is C
1
-C
4
alkyl and R
7
is C
1
-C
4
alkyl, fluoromethyl or chloromethyl; and the dotted line in ring A indicates that the 1,2-linkage is saturated or unsaturated; with the proviso that when R is C
1
-C
4
alkyl, then R
5
is —OH.
ENHANCEMENT OF ACTIVITY AND/OR DURATION OF ACTION OF SELECTED ANTI-INFLAMMATORY STEROIDS FOR TOPICAL OR OTHER LOCAL APPLICATION
申请人:Bodor Nicholas S.
公开号:US20080261930A1
公开(公告)日:2008-10-23
Methods and compositions for enhancing the activity and/or duration of action of soft anti-inflammatory steroids of the haloalkyl 17α-alkoxy-11β-hydroxyandrost-4-en-3-one-17β-carboxylate type and the corresponding Δ
1,4
compounds and of anti-inflammatory steroids of the hydrocortisone and prednisolone type are described. The enhancing agents have the formula:
wherein R is H or C
1
-C
4
alkyl; Z
1
is carbonyl or β-hydroxymethylene; X
1
is —O— or —S—; R
5
is —OH, —OR
6
, —OCOOR
6
or —OCOR
7
wherein R
6
is C
1
-C
4
alkyl and R
7
is C
1
-C
4
alkyl, fluoromethyl or chloromethyl; and the dotted line in ring A indicates that the 1,2-linkage is saturated or unsaturated; with the proviso that when R is C
1
-C
4
alkyl, then R
5
is —OH.